Global elimination of trachoma: how frequently should we administer mass chemotherapy?
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 10229236.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The World Health Organization has recommended repeat mass drug administration as part of their global initiative to eliminate blinding trachoma by the year 2020. The efficacy of repeat treatment will be tested empirically, but the results will not be available for many years, and recommendations for the necessary frequency of treatment are needed immediately. We have developed a mathematical model that uses available epidemiological data from a variety of countries. We recommend, based on our analysis, that in areas where trachoma is moderately prevalent (<35% in children), it should be treated annually, but hyperendemic areas (>50% in children), it should be treated biannually.
Medical subject headings
- Azithromycin
- Blindness
- Computer Simulation
- Models, Theoretical
- Trachoma